Influence of perception of glucocorticoids on compliance of treatment in patients with rheumatoid arthritis and systemic lupus erythematosus

Reichardt, 2021, The role of glucocorticoids in inflammatory diseases, Cells, 10, 2921, 10.3390/cells10112921 Morin, 2015, Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients, Clin Rheumatol, 34, 2119, 10.1007/s10067-015-2953-7 Burns, 2016, The history of cortisone discovery and development, Rheum Dis Clin North Am, 42, 1, 10.1016/j.rdc.2015.08.001 Smolen, 2020, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update, Ann Rheum Dis, 79, 685, 10.1136/annrheumdis-2019-216655 Mejía-Vilet, 2021, The use of glucocorticoids in lupus nephritis: new pathways for an old drug, Front Med, 8, 10.3389/fmed.2021.622225 Barton, 2020, New galaxies in the universe of shared decision making and rheumatoid arthritis, CurrOpin Rheumatol, 32, 273 Sakr, 2022, Relationship of adherence to treatment with disease activity, physical function, quality of life, treatment satisfaction and beliefs in axial spondyloarthritis patients, Egypt. Rheumatol., 44, 191, 10.1016/j.ejr.2021.12.001 Petri, 2012, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum., 64, 2677, 10.1002/art.34473 Aletaha, 2010, 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum., 62, 2569, 10.1002/art.27584 Horne, 1999, The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication, Psychol. Health, 14, 1, 10.1080/08870449908407311 de Klerk, 2003, The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study, J. Rheumatol., 30, 2469 Ziadé, 2020, Transcultural Adaptation and Validation of the Arabic Version of the Compliance Questionnaire for Rheumatology, Acta Sci. Orthop., 3, 26, 10.31080/ASOR.2020.03.0215 El-Gilany, 2012, Updating and validation of the socioeconomic status scale for health research in Egypt, East Mediterr. Health J., 18, 962, 10.26719/2012.18.9.962 Black, 2017, A Survey of glucocorticoid adverse effects and benefits in rheumatic diseases: The patient perspective, J Clin. Rheumatol., 23, 416, 10.1097/RHU.0000000000000585 Bertsias, 2012, Systemic lupus erythematosus: pathogenesis and clinical features, EULAR Textbk. Rheum. Diseases, 5, 476 Gulati, 2018, Clinical features of rheumatoid arthritis, Medicine, 46, 211, 10.1016/j.mpmed.2018.01.008 Macejová, 2013, Systemic lupus erythematosus–disease impact on patients, Cent Eur J Public Health, 21, 171, 10.21101/cejph.a3818 Mosca, 2011, Glucocorticoids in systemic lupus erythematosus, Clin Exp Rheumatol, 29, S126 Dadonienė, 2021, Mortality in inflammatory rheumatic diseases: Lithuanian national registry data and systematic review, Int J Environ Res Public Health, 18, 12338, 10.3390/ijerph182312338 Venter, 2021, Perspectives of glucocorticoid use in patients with rheumatoid arthritis, ACR Open Rheumatol, 3, 231, 10.1002/acr2.11234 Neame, 2005, Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis, Rheumatology, 44, 762, 10.1093/rheumatology/keh587 Nogué, 2019, Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient, BMC Health Serv Res, 19, 255, 10.1186/s12913-019-4052-y Kumar, 2011, It’s like taking poison to kill poison but I have to get better’: A qualitative study of beliefs about medicines in Rheumatoid arthritis and Systemic lupus erythematosus patients of South Asian origin, Lupus, 20, 837, 10.1177/0961203311398512 Patel, 2013, Herbal medicine− A natural cure to arthritis, Indian J Nat Prod Resour, 4, 27 Rao, 1999, Use of complementary therapies for arthritis among patients of rheumatologists, Ann Int Med, 131, 409, 10.7326/0003-4819-131-6-199909210-00003 Rashid, 2020, Herbal medication triggering lupus nephritis-a case report, BMC Compl Med And Therap, 20, 1 Zhong, 2013, Chinese herbal medicine (Zi Shen Qing) for mild-to-moderate systematic lupus erythematosus: a pilot prospective, single-blinded, randomized controlled study, J Evid Based Complement Altern Med, 2013, 1 Chambers, 2008, Factors influencing adherence to medications in a group of patients with systemic erythematosus in Jamaica, Lupus, 17, 761, 10.1177/0961203308089404 Sagy, 2022, Lower socioeconomic status worsens outcome of patients with systemic lupus erythematosus independently of access to healthcare, Lupus, 31, 532, 10.1177/09612033221084518 Gamal, 2021, Effect of education on disease activity and functional status in rheumatoid arthritis patients, Egypt Rheumatol, 43, 7, 10.1016/j.ejr.2020.12.001 Ragab, 2017, Effect of early treatment with disease-modifying anti-rheumatic drugs and treatment adherence on disease outcome in rheumatoid arthritis patients, Egypt Rheumatol, 39, 69, 10.1016/j.ejr.2016.11.004 Dougados, 2014, Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Ann Rheum Dis, 73, 62, 10.1136/annrheumdis-2013-204223 van Onna, 2018, Disease and management beliefs of elderly patients with rheumatoid arthritis and comorbidity: a qualitative study, Clin Rheumatol, 37, 2367, 10.1007/s10067-018-4167-2 Mcelhone, 2006, A review of health-related quality of life in systemic lupus erythematosus, Lupus, 15, 633, 10.1177/0961203306071710 Porta, 2020, Glucocorticoids in Systemic Lupus Erythematosus. Ten questions and some issues, J Clin Med, 9, 2709, 10.3390/jcm9092709 Ruiz-Irastorza, 2012, Glucocorticoid use and abuse in SLE, Rheumatology, 51, 1145, 10.1093/rheumatology/ker410 Roubille, 2015, The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and GCs on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis, Ann Rheum Dis, 74, 480, 10.1136/annrheumdis-2014-206624 Strehl, 2016, Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR Task force, Ann Rheum Dis, 75, 952, 10.1136/annrheumdis-2015-208916 Contento, 2021, Steroid Phobia: a review of prevalence, risk factors, and interventions, Am J Clin Dermatol, 22, 837, 10.1007/s40257-021-00623-6 Shahin, 2019, The impact of personal and cultural beliefs on medication adherence of patients with chronic illnesses: a systematic review, Patient Prefer Adher, 13, 1019, 10.2147/PPA.S212046